Beijing Luzhu Biotechnology Co., Ltd. (HKG:2480)
Hong Kong
· Delayed Price · Currency is HKD
23.80
-0.50 (-2.06%)
Last updated: Mar 9, 2026, 3:30 PM HKT
HKG:2480 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 45.63 | 64.8 | 87.01 | 85.83 | 60.22 |
| Research & Development | 105.03 | 135.13 | 172.69 | 91.43 | 42.98 |
| Other Operating Expenses | 1.14 | 0.75 | 0.6 | 3.14 | 9.04 |
| Operating Expenses | 151.81 | 200.67 | 260.3 | 180.39 | 112.24 |
| Operating Income | -151.81 | -200.67 | -260.3 | -180.39 | -112.24 |
| Interest Expense | -3.77 | -1.44 | -0.84 | -0.72 | -0.6 |
| Interest & Investment Income | 2.14 | 3.52 | 6.01 | 0.25 | 0.04 |
| Currency Exchange Gain (Loss) | -1.1 | 1 | 6.73 | 1 | 0 |
| Other Non Operating Income (Expenses) | 15.05 | 18.55 | -12.38 | -559.41 | -437.35 |
| EBT Excluding Unusual Items | -139.5 | -179.06 | -260.78 | -739.28 | -550.15 |
| Gain (Loss) on Sale of Investments | 9.32 | 11.1 | 11.38 | 13.87 | 10.8 |
| Gain (Loss) on Sale of Assets | -0.25 | -0.25 | 0.06 | -0 | -0.01 |
| Other Unusual Items | - | -0.03 | - | 0.24 | - |
| Pretax Income | -135.87 | -168.24 | -249.35 | -725.18 | -539.36 |
| Net Income | -135.87 | -168.24 | -249.35 | -725.18 | -539.36 |
| Net Income to Common | -135.87 | -168.24 | -249.35 | -725.18 | -539.36 |
| Shares Outstanding (Basic) | 201 | 202 | 199 | 146 | 91 |
| Shares Outstanding (Diluted) | 201 | 202 | 199 | 146 | 91 |
| Shares Change (YoY) | -0.85% | 1.48% | 36.65% | 60.39% | - |
| EPS (Basic) | -0.68 | -0.83 | -1.25 | -4.98 | -5.94 |
| EPS (Diluted) | -0.68 | -0.83 | -1.25 | -4.98 | -5.94 |
| Free Cash Flow | -220.75 | -180.45 | -275.72 | -285.47 | -79.08 |
| Free Cash Flow Per Share | -1.10 | -0.89 | -1.39 | -1.96 | -0.87 |
| EBITDA | -125.34 | -179.15 | -248.65 | -174.97 | -109.42 |
| D&A For EBITDA | 26.46 | 21.53 | 11.65 | 5.42 | 2.83 |
| EBIT | -151.81 | -200.67 | -260.3 | -180.39 | -112.24 |
Source: S&P Capital IQ. Standard template.
Financial Sources.